0:15 Intro

3:39 Update in pre-lung cancer genome atlas research

17:06 Next steps: applying innovations in bronchoscopy

21:45 When we can anticipate results

25:05 Understanding the lung’s microbiome

29:21 Utility of fragmentomics

31:01 Outro

Dr. Steven Dubinett at University of California, Los Angeles and Dr. Avrum Spira at Boston University revisit our virtual studio to provide an update on their lung cancer interception research, as currently funded by the American Lung Association and LUNGevity Foundation. With the goal of combating cancer at a preliminary stage, Drs. Dubinett and Spira are focused on refining molecular and imaging markers to help identify high-risk premalignant lesions. These findings hope to lead to future therapeutics halting the progression of cells likely to cause invasive cancer.

Want more Lungcast? Visit us at HCPLive.com/podcasts/lungcast or www.lung.org/professional-education/lungcast